Linperlisib Combined With EZH2 Inhibitor in Relapsed/Refractory Peripheral T-cell Lymphoma (PTCL)
Clinical trial NCT06712173 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06712173
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-01
- Primary completion
- 2025-09-30
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.